MOZARNIS Trademark Information

Glaxo Group Limited

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncolog...

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations   substances   treatment   damaged   skin   tissue   pharmaceutical   preparations   substances   treatment   infectious   diseases     blood   disorders     pain     inflammation     sepsis     alopecia     obesity  

This is a brand page for the MOZARNIS trademark by Glaxo Group Limited  in Brentford, Middlesex, , TW89GS.

Write a review about a product or service associated with this MOZARNIS trademark. Or, contact the owner Glaxo Group Limited of the MOZARNIS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the MOZARNIS trademark.

Status Update! On Monday, September 30, 2019, status on the MOZARNIS trademark changed to FOURTH EXTENSION - GRANTED.

On Friday, April 14, 2017, a U.S. federal trademark registration was filed for MOZARNIS. The USPTO has given the MOZARNIS trademark serial number of 87411799. The current federal status of this trademark filing is FOURTH EXTENSION - GRANTED. The correspondent listed for MOZARNIS is CHRISTOPHER M. HANES of GSK, LGTM, 5.5A, 5 MOORE DRIVE RESEARCH TRIANGLE PARK NC 27709-3398 . The MOZARNIS trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for MOZARNIS is Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines.

Word mark: MOZARNIS
Status/Status Date:
FOURTH EXTENSION - GRANTED
9/30/2019
Serial Number: 87411799
Filing Date: 4/14/2017
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 8/8/2017
Last Applicant/Owner: Glaxo Group Limited
Brentford, Middlesex TW89GS
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
GSK
LGTM, 5.5A
5 MOORE DRIVE
RESEARCH TRIANGLE PARK NC 27709-3398

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your MOZARNIS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
9/30/2019
FOURTH EXTENSION - GRANTED
Correspondent Search:

CHRISTOPHER M. HANES is a correspondent of MOZARNIS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!